Aurobindo Pharma Ltd. - Research Center
524804 AUROPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Profit before tax | 1,614.35 | 1,637.48 | 4,193.01 | 1,964.62 | 2,342.94 |
| Net cashflow-operating activity | 1,821.16 | 3,726.71 | 2,994.41 | 526.71 | 922.40 |
| Net cash used in investing activity | -3,459.68 | -1,613.51 | -2,648.73 | -1,297.36 | -990.60 |
| Netcash used in fin. activity | 1,719.48 | -2,447.54 | -27.94 | 599.40 | 439.69 |
| Net inc/dec in cash and equivlnt | 81.44 | -335.37 | 316.23 | -171.25 | 371.49 |
| Cash and equivalnt begin of year | 48.21 | 383.58 | 67.35 | 239.95 | -131.54 |
| Cash and equivalnt end of year | 129.65 | 48.21 | 383.58 | 68.70 | 239.95 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis